Literature DB >> 16865390

Pharmacokinetics of a netilmicin loading dose on the first postnatal day in preterm neonates with very low gestational age.

Jens Rengelshausen1, Bernd Beedgen, Konstantina Tsamouranis, Gerd Mikus, Ingeborg Walter-Sack, Walter E Haefeli, Otwin Linderkamp.   

Abstract

OBJECTIVE: Pharmacokinetic parameters are important for dose adjustment of aminoglycosides, but they are highly variable in neonates. In this study the pharmacokinetics of a netilmicin loading dose was investigated on the first postnatal day in preterm neonates with very low gestational age (GA).
METHODS: In an open prospective study, 20 neonates with GA between 22.9 and 32.0 weeks and suspected postnatal bacterial infection received an intravenous loading dose of 5 mg/kg netilmicin over 1 h during the first postnatal day. Netilmicin serum concentrations were determined by an enzyme multiplied immunoassay.
RESULTS: The systemic clearance of netilmicin normalized to body weight (BW) was not significantly different in three GA subgroups (0.59+/- 0.02 ml/min/kg for GA <24 weeks, 0.72+/-0.14 ml/min/kg for GA 24-27 weeks, and 0.62+/-0.19 ml/min/kg for GA 27-32 weeks, P=0.123). Similar results were also obtained for serum elimination half-time and for the distribution volume normalized to BW. Multiple regression analysis showed that systemic clearance and volume of distribution (both not normalized to BW) significantly correlated with BW (P<0.0001) but not with GA. In the entire group, 20% of peak concentrations were below the target of 6 mg/l, and 63% of trough concentrations were above the target of 2 mg/l.
CONCLUSION: In neonates with very low GA, the pharmacokinetic parameters of netilmicin determined after an intravenous loading dose were not dependent on GA when normalized to BW. A number of neonates did not reach targeted peak and trough netilmicin serum concentrations, suggesting that a higher loading dose and a prolonged dosing interval might enhance the effectiveness and safety of netilmicin in preterm neonates immediately after birth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865390     DOI: 10.1007/s00228-006-0153-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

Review 1.  A critical reevaluation of the "therapeutic range" of aminoglycosides.

Authors:  J P McCormack; P J Jewesson
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

2.  Comparison of two gentamicin dosing schedules in very low birth weight infants.

Authors:  Alok Rastogi; Ghanshyam Agarwal; Suma Pyati; Rosita S Pildes
Journal:  Pediatr Infect Dis J       Date:  2002-03       Impact factor: 2.129

Review 3.  Clinical pharmacokinetics of antibacterial drugs in neonates.

Authors:  C M Paap; M C Nahata
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 4.  Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.

Authors:  E Nestaas; H-J Bangstad; L Sandvik; K-O Wathne
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-27       Impact factor: 5.747

5.  Short antibiotic prophylaxis for bacterial infections in a neonatal intensive care unit: a randomized controlled trial.

Authors:  C Auriti; L Ravà; V Di Ciommo; M P Ronchetti; M Orzalesi
Journal:  J Hosp Infect       Date:  2005-04       Impact factor: 3.926

6.  Extended-interval aminoglycoside administration for children: a meta-analysis.

Authors:  Despina G Contopoulos-Ioannidis; Nikos D Giotis; Dimitra V Baliatsa; John P A Ioannidis
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

7.  Use of once-daily netilmicin to treat infants with suspected sepsis in a neonatal intensive care unit.

Authors:  J R Brooks; N Marlow; B C Reeves; M R Millar
Journal:  Biol Neonate       Date:  2004-06-29

8.  Netilmicin in the neonate: population pharmacokinetic analysis and dosing recommendations.

Authors:  K Fattinger; S Vozeh; A Olafsson; J Vlcek; M Wenk; F Follath
Journal:  Clin Pharmacol Ther       Date:  1991-07       Impact factor: 6.875

9.  Clinical pharmacology of netilmicin in preterm and term newborn infants.

Authors:  B Granati; B M Assael; M Chung; C Montini; R Parini; P Pollazzon; L Gagliardi; E Radwanski; F F Rubaltelli
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

10.  Validation of a simplified netilmicin dosage regimen in infants.

Authors:  Claus Klingenberg; Lars Småbrekke; Tore Lier; Trond Flaegstad
Journal:  Scand J Infect Dis       Date:  2004
View more
  3 in total

1.  Interindividual variability of aminoglycoside pharmacokinetics in preterm neonates at birth.

Authors:  Karel Allegaert; Brian J Anderson
Journal:  Eur J Clin Pharmacol       Date:  2006-09-28       Impact factor: 2.953

2.  Individualising netilmicin dosing in neonates.

Authors:  Catherine M T Sherwin; Roland S Broadbent; Natalie J Medlicott; David M Reith
Journal:  Eur J Clin Pharmacol       Date:  2008-08-07       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of aminoglycosides in the neonate: a review.

Authors:  Gian Maria Pacifici
Journal:  Eur J Clin Pharmacol       Date:  2008-12-23       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.